Classification of HHV-6A and HHV-6B as distinct viruses
Dharam V. Ablashi(HHV-6 Foundation), Tetsushi Yoshikawa(Fujita Health University), Mario Luppi(University of Modena and Reggio Emilia), Joshua C. Pritchett(Mayo Clinic Health System), Roberto Álvarez‐Lafuente(Hospital Clínico San Carlos), Peter G. Medveczky(University of South Florida), Mauro Malnati, Paolo Lusso(National Institute of Allergy and Infectious Diseases), Steven Jacobson(National Institute of Neurological Disorders and Stroke), Yasuko Mori(Kobe University), Per Höllsberg(Aarhus University), Philip E. Pellett(Wayne State University), Stephen Dewhurst(University of Rochester Medical Center), Duncan A. Clark(Barts Health NHS Trust), Henri Agut(Pitié-Salpêtrière Hospital), Louis Flamand(Centre hospitalier universitaire de Québec), Dario Di Luca(University of Ferrara), Koichi Yamanishi(The University of Osaka), Ursula A. Gompels(University of London), Niza Frenkel(Tel Aviv University), Robert C. Gallo(University of South Florida)
Cited by 360
Related Papers
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537